Alnylam Pharmaceuticals
ALNY
#595
Rank
$41.93 B
Marketcap
$314.32
Share price
1.20%
Change (1 day)
32.76%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company